Therapeutic Proteins
Recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, autoimmunity/inflammation, exposure to infectious agents, and genetic disorders. Combining years of owner’s side experience, we know the processes and technologies to design and construct therapeutic protein manufacturing facilities.
Featured Therapeutic Proteins Experts
-
Jason S. Collins, AIA
Director of Process Architecture
-
Catherine Jomary
Technology Lead ATMPs
-
Thomas J. Piombino
Managing Director, Americas
-
Mark E. Rezac, PE
Director, Compliance Services
-
Joseph J. Rotman
Lead Process Engineer
-
Tim Schuster
Director, Process Engineering
-
George Todorov
Sr. Process Technologist
-
Aaron Weinstein
Sr. Director, Validation Services
-
Michael Westerman
Sr. Director, CQV Operations
